Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Hou, Lianguo ^a   Lian, Kaoqi ^a   Yao, Min ^a   Shi, Yun ^a   Lu, Xin ^a   Fang, Lijia ^a   He, Tianbo ^a   Jiang, Lingling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

DHA; EPA; FAO; n 3 PUFA; Peroxisomal oxidation; T2DM

Indexed keywords

ADRENIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HEART; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACYL-COA OXIDASE; ANIMALS; CHROMATOGRAPHY, GAS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENERGY METABOLISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATION-REDUCTION; PEROXISOMES; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84867234920     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-126     Document Type: Article

References (34)

1. Fox CS, Coady S, Sorlie PD, D'Agostino RB, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115(12):1544-1550. 10.1161/CIRCULATIONAHA.106.658948, 17353438.
2. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005, 1734(2):112-126. 10.1016/j.bbalip.2005.03.005, 15904868.
3. van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res 2011, 92(1):10-18. 10.1093/cvr/cvr212, 21803867.
4. Hu Q, Ishii E, Nakagawa Y. Differential changes in relative levels of arachidonic acid in major phospholipids from rat tissues during the progression of diabetes. J Biochem 1994, 115(3):405-408.
5. Ovide-Bordeaux S, Grynberg A. Docosahexaenoic acid affects insulin deficiency- and insulin resistance-induced alterations in cardiac mitochondria. Am J Physiol Regul Integr Comp Physiol 2004, 286(3):R519-R527. 10.1152/ajpregu.00303.2003, 14604840.
6. Camoes F, Bonekamp NA, Delille HK, Schrader M. Organelle dynamics and dysfunction: A closer link between peroxisomes and mitochondria. J Inherit Metab Dis 2009, 32(2):163-180. 10.1007/s10545-008-1018-3, 19067229.
7. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000, 20(5):1868-1876. 10.1128/MCB.20.5.1868-1876.2000, 85369, 10669761.
8. Razny U, Kiec-Wilk B, Wator L, Polus A, Dyduch G, Solnica B, Malecki M, Tomaszewska R, Cooke JP, Dembinska-Kiec A. Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol 2011, 10:68. 10.1186/1475-2840-10-68, 3212914, 21781316.
9. Koopmans SJ, Dekker R, Ackermans MT, Sauerwein HP, Serlie MJ, van Beusekom HM, van den Heuvel M, van der Giessen WJ. Dietary saturated fat/cholesterol, but not unsaturated fat or starch, induces C-reactive protein associated early atherosclerosis and ectopic fat deposition in diabetic pigs. Cardiovasc Diabetol 2011, 10:64. 10.1186/1475-2840-10-64, 3143922, 21756316.
10. Bilbao E, Cajaraville MP, Cancio I. Cloning and expression pattern of peroxisomal beta-oxidation genes palmitoyl-CoA oxidase, multifunctional protein and 3-ketoacyl-CoA thiolase in mussel Mytilus galloprovincialis and thicklip grey mullet Chelon labrosus. Gene 2009, 443(1-2):132-142.
11. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002, 109(1):121-130. 150824, 11781357.
12. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ, . American Heart Association; American Diabetes Association Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007, 115(1):114-126. American Heart Association; American Diabetes Association.
13. Chicco AJ, Sparagna GC, McCune SA, Johnson CA, Murphy RC, Bolden DA, Rees ML, Gardner RT, Moore RL. Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets. Hypertension 2008, 52(3):549-555. 10.1161/HYPERTENSIONAHA.108.114264, 2864132, 18663155.
14. Baur LA, O'Connor J, Pan DA, Kriketos AD, Storlien LH. The fatty acid composition of skeletal muscle membrane phospholipid: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 1998, 47(1):106-112. 10.1016/S0026-0495(98)90202-5, 9440487.
15. Slee EL, McLennan PL, Owen AJ, Theiss ML. Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J Lipid Res 2010, 51(7):1841-1848. 10.1194/jlr.M004069, 2882742, 20219901.
16. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005, 52(4):313-320. 10.1016/j.phrs.2005.05.004, 15979893.
17. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49(11):1390-1394. 10.1053/meta.2000.17721, 11092499.
18. Coste TC, Deumer G, Reychler G, Lebecque P, Wallemacq P, Leal T. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis. Clin Chem 2008, 54(2):388-395. 10.1373/clinchem.2007.094623, 18089657.
19. Lepage G, Roy CC. Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J Lipid Res 1988, 29(2):227-235.
20. Osmundsen H, Brodal B, Hovik R. A luminometric assay for peroxisomal beta-oxidation. Effects of fasting and streptozotocin-diabetes on peroxisomal beta-oxidation. Biochem J 1989, 260(1):215-220. 1138648, 2775184.
21. Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 2003, 1:e012. 1402222, 16604184.
22. Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids 2011, 85(5):219-225. 10.1016/j.plefa.2011.04.018, 21571515.
23. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 2000, 45(2):279-293. 10.1016/S0008-6363(99)00263-1, 10728348.
24. Pulinilkunnil T, Rodrigues B. Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease. Cardiovasc Res 2006, 69(2):329-340. 10.1016/j.cardiores.2005.09.017, 16307734.
25. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006, 291(4):H1489-H1506. 10.1152/ajpheart.00278.2006, 16751293.
26. Poirier Y, Antonenkov VD, Glumoff T, Hiltunen JK. Peroxisomal beta-oxidation-a metabolic pathway with multiple functions. Biochim Biophys Acta 2006, 1763(12):1413-1426. 10.1016/j.bbamcr.2006.08.034, 17028011.
27. Ferdinandusse S, Denis S, Dacremont G, Wanders RJ. Studies on the metabolic fate of n-3 polyunsaturated fatty acids. J Lipid Res 2003, 44(10):1992-1997. 10.1194/jlr.M300223-JLR200, 12897190.
28. Van Veldhoven PP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res 2010, 51(10):2863-2895. 10.1194/jlr.R005959, 2936746, 20558530.
29. Igarashi M, Ma K, Chang L, Bell JM, Rapoport SI. Rat heart cannot synthesize docosahexaenoic acid from circulating alpha-linolenic acid because it lacks elongase-2. J Lipid Res 2008, 49(8):1735-1745. 10.1194/jlr.M800093-JLR200, 18456640.
30. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77(6):937-946. 10.1016/j.bcp.2008.10.020, 19022225.
31. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008, 83(3):324-332. 10.4065/83.3.324, 18316000.
32. Vrablik M, Prusikova M, Snejdrlova M, Zlatohlavek L. Omega-3 fatty acids and cardiovascular disease risk: do we understand the relationship?. Physiol Res 2009, 58(Suppl 1):S19-S26.
33. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 2005, 146(12):5341-5349. 10.1210/en.2005-0938, 16141388.
34. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, Kelly DP. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci U S A 2003, 100(3):1226-1231. 10.1073/pnas.0336724100, 298755, 12552126.